NewAmsterdam Pharma Company NV
NAMS21.409USD
+0.129+0.61%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
2.40BMarket Cap
LossP/E TTM
NewAmsterdam Pharma Company NV
21.409
+0.129+0.61%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2022Q4
FY2022Q2
Total equity
Cash, cash equivalents and short-term investments
68.03%808.48M
145.03%834.19M
--422.73M
--430.71M
--481.15M
-27.21%340.45M
--467.73M
--93.79M
- Cash and cash equivalents
55.55%748.42M
126.68%771.74M
--422.73M
--430.71M
--481.15M
-27.21%340.45M
--467.73M
--93.79M
-Short-term investments
--60.06M
--62.45M
----
----
----
----
----
----
Receivables
-60.97%1.61M
1032.64%21.30M
--5.15M
--5.41M
--4.13M
-9.13%1.88M
--2.07M
--121.18M
-Accounts and notes receivable
----
----
----
----
----
----
----
--120.54M
-Other receivables
-63.81%1.44M
2298.17%20.98M
--1.65M
--2.13M
--3.98M
--875.00K
--0.00
----
Prepaid expenses
183.79%7.21M
77.53%7.92M
--10.00M
--9.24M
--2.54M
-45.48%4.46M
--8.18M
--12.44M
Other current assets
---171.00K
----
----
----
----
----
----
----
Total current assets
67.54%817.30M
148.97%863.41M
--437.87M
--445.35M
--487.82M
-27.45%346.79M
--477.98M
--227.41M
Non-current assets
Net Fixed Assets
336.69%607.00K
566.34%673.00K
--724.00K
--788.00K
--139.00K
-34.42%101.00K
--154.00K
--183.43K
Goodwill and other intangible assets
3.29%502.00K
214.12%534.00K
--593.00K
--542.00K
--486.00K
-18.27%170.00K
--208.00K
----
Long-term debt
----
----
----
----
----
----
----
--763.09K
Long-term prepaid expenses
----
-100.00%0.00
----
--8.00K
--16.00K
-77.56%35.00K
--156.00K
----
Other non-current assets
-100.00%0.00
-100.00%0.00
----
--8.00K
--16.00K
-77.56%35.00K
--156.00K
----
Total non-current assets
73.01%1.11M
294.44%1.21M
--1.32M
--1.34M
--641.00K
-40.93%306.00K
--518.00K
--946.52K
Total assets
67.55%818.41M
149.10%864.62M
--439.19M
--446.69M
--488.46M
-27.46%347.10M
--478.50M
--228.35M
Liabilities
Current liabilities
-Other payables
--0.00
----
----
----
----
----
----
----
Accrued expenses
-19.55%8.02M
19.39%13.61M
--10.58M
--10.19M
--9.97M
86.33%11.40M
--6.12M
----
Short-term debt and lease liabilities
----
----
----
----
----
-9.09%60.00K
--66.00K
--63.94K
-Short-term lease liabilities
----
----
----
----
----
-9.09%60.00K
--66.00K
--63.94K
Deferred liabilities
-62.67%3.03M
-32.81%6.01M
--4.50M
--6.06M
--8.12M
-35.55%8.94M
--13.87M
--14.74M
Other current liabilities
-62.67%3.03M
-32.81%6.01M
--4.50M
--6.06M
--8.12M
-35.55%8.94M
--13.87M
--14.74M
Total current liabilities
-31.50%40.91M
114.28%106.92M
--41.26M
--45.31M
--59.73M
38.38%49.90M
--36.06M
--27.15M
Non-current liabilities
Long-term debt and lease liabilities
--137.00K
--202.00K
--266.00K
--328.00K
--0.00
--0.00
--0.00
--0.00
-Long-term lease liabilities
--137.00K
--202.00K
--266.00K
--328.00K
----
----
----
----
Deferred liabilities
----
-100.00%0.00
--0.00
--222.00K
--444.00K
-78.74%1.02M
--4.79M
--7.80M
Derivatives liabilities
----
-100.00%0.00
--18.81M
--13.39M
--16.49M
3.54%7.79M
--7.52M
----
Other non-current liabilities
-100.00%0.00
-100.00%0.00
--0.00
--222.00K
--444.00K
-78.74%1.02M
--4.79M
--7.80M
Total non-current liabilities
-99.19%137.00K
-97.71%202.00K
--19.07M
--13.94M
--16.93M
-28.83%8.81M
--12.37M
--7.89M
Total liabilities
-46.45%41.05M
82.47%107.12M
--60.33M
--59.25M
--76.66M
21.21%58.70M
--48.43M
--35.04M
Shareholders' equity
Common equity
67.58%1.37B
118.26%1.31B
--840.83M
--832.76M
--818.12M
6.23%600.94M
--565.68M
--171.44M
Retained earnings
-45.61%-598.10M
-76.22%-558.57M
---466.39M
---449.75M
---410.74M
-126.35%-316.97M
---140.04M
--20.79M
Capital reserves
68.16%1.36B
119.74%1.30B
--829.40M
--821.61M
--807.01M
6.33%590.77M
--555.63M
----
Gains losses not affecting retained earnings
0.27%4.43M
1.02%4.47M
--4.42M
--4.42M
--4.42M
0.00%4.42M
--4.42M
----
Total equity
88.77%777.36M
162.66%757.50M
--378.86M
--387.44M
--411.80M
-32.94%288.39M
--430.07M
--193.31M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
